Saphnelo approved in the US for subcutaneous self‑administration
27th April 2026 Uncategorised 0
Greater flexibility for people with systemic lupus erythematosus

More: Saphnelo approved in the US for subcutaneous self‑administration
Source: News
Greater flexibility for people with systemic lupus erythematosus

More: Saphnelo approved in the US for subcutaneous self‑administration
Source: News
© 1994 - 2026 B.M. Pharmaceuticals